GCP
SZYM

GSA Capital Partners’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

GSA Capital Partners’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-19,600
Closed -$231K – 2089
2014
Q2 		$231K Buy
19,600
+9,300
+90% +$99.2K 0.01% 1546
2014
Q1 		$120K Buy
+10,300
New +$121K 0.01% 1457

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

GSA Capital Partners's SZYM Position: Q3 2014 in Review

GSA Capital Partners sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2014, closing a stake of 19,600 shares — an estimated $231K sold.

GSA Capital Partners first reported a position in SZYM in Q1 2014 and held it in 2 quarters. The position peaked at $231K in Q2 2014. 120 funds tracked by Wall St. Rank hold SZYM as of Q3 2014.

  • GSA Capital Partners reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • GSA Capital Partners sold 19,600 SOLAZYME INC COM STK (DE) shares in Q3 2014, an estimated $231K.
  • GSA Capital Partners first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • GSA Capital Partners's SOLAZYME INC COM STK (DE) position peaked at $231K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2014.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.